Hard to Treat Diseases Inc. Stem Cell Developments
HTDS postponed these merger negotiations due to certain HTDS’ “followers” certain intrusive intervention and a massive short position on HTDS security. As previously announced, the company has begun a project to build its own stem cell lab. Details …
[Read the full article here]Related News:
Hard To Treat Diseases (HTDS) Exploration Of A 25 Billion Dollar Industry Regenerative Medicine and Stem Cell Bank …
Hard to Treat Diseases Inc. Targets an EU Based Stem Cell …
HTDS announces possible merger with EU-based, stem-cell research company